To add to that, the Welsh biotech’s partnership with the University of Wales Trinity Saint David’s (UWTSD) Assistive Technologies Innovation Centre (ATiC) and the TriTech Institute successfully came ...

Kymera Therapeutics raises $250.8M in public offering to advance its innovative degrader medicines for immunological diseases.

An Ireland-based healthcare company is stealing the show so far during Tuesday’s session after it was announced that the ...

The approval enables Trinity to transition upstream production from in-house operations to an outsourced model.